##semicolon##
yurak, yurak ishemik kasalligi, surunkali yurak yetishmovchiligi, polimorfizm.##submission.citations##
Asadov ZX, Yakubov UK Early diagnostics dysfunction myocardium he/she sick IBS c ispolzovaniem Speckle-tracking echocardiography. // Vestnik cardiology Uzbekistan. – 2021. – No. 4. - P. 33-38.
Bokeria LA, Mazur NA Chronic heart failure. - M.: Izd-vo Binom, 2021. - 432 p.
Braunwald E. Heart Disease: A Textbook of Cardiovascular Medicine. - 11th ed. – Philadelphia: Elsevier, 2018. – 2060 p.
Casper DL, Fauci AS Harrison's Principles of Internal Medicine. - 21st ed. – New York: McGraw-Hill, 2022. – Vol. 1–2. - 4300 p.
Chair, SY, Wong, TKS, & Cheng, HY (2021). Non-coding RNAs as biomarkers and therapeutic targets for heart failure. Journal of Clinical Medicine, 10(4), 855. DOI: https://doi.org/10.3390/jcm1004 0855 .
Fan, Y., Zhang, H., & Zhao, X. (2022). Multi-omics analysis identifies potential biomarkers and therapeutic targets in heart failure. BMC Genomics, 23(1), 741. DOI: https://doi.org/10.1186/s12864-022-08971-0
Gheorghiade M., Bonow RO Chronic heart failure in ischemic heart disease. // J Am Coll Cardiol. - 2017. - Vol. 70(4). – P. 470–483.
Januzzi JL et al. Natriuretic Peptides in Heart Failure: Biochemistry, Physiology and Clinical Use. // Eur Heart J. – 2020. – Vol. 41. – P. 1900–1908.
Lang RM et al. Recommendations for Cardiac Chamber Quantification by Echocardiography. // J Am Soc Echocardiogr. - 2015. - Vol. 28. – P. 1–39.
McDonagh TA et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. // European Heart Journal. - 2021. - Vol. 42(36). – P. 3599–3726.
Ridker PM, Libby P. Inflammation in Atherosclerosis: From Pathophysiology to Practice. // J Am Coll Cardiol. - 2021. - Vol. 78. – P. 1938–1956.
Shlyakhto Ye.V., Lebedev DS, Kovalenko VN Ischemic disease of the heart and heart failure. - SPb.: Polytechnic, 2020. - 388 p.
Shrivastava, S., & Dhingra, S. (2020). Genetic and proteomic biomarkers in heart failure: A systematic review. Frontiers in Cardiovascular Medicine, 7, 585. DOI: https://doi.org/10.3389/fcvm.20 20.00585
Trukhan D. I., Burdina A. V. Sovremennye aspects of diagnosis of cardiac insufficiency: the role of natriuretic peptides. // Cardiology. – 2019. – No. 2. - S. 58–63.
Tsutsui H., Tsuchihashi-Makaya M. Clinical characteristics and outcomes in patients with heart failure. // Circ J. – 2018. – Vol. 82. – P. 278–284.
Vilensky B. S. Cardiology: current management – M.: GEOTAR - Media, 2019. – 640 p.
Wasan, RS, & Benjamin, EJ (2021). The genetic basis of heart failure: Integrating omics and artificial intelligence. Nature Reviews Cardiology, 18(9), 643–656. DOI: https://doi.org/10.1038/s415 69-021-00530-2
Yancy CW et al. ACCF/AHA Guideline for the Management of Heart Failure. // Circulation. - 2017. - Vol. 136. – P. e137–e161.
Yermakova T. Ye., Belova I. V. Significance of markers of inflammation and diagnosis of cardiac insufficiency. // Russian Cardiology Journal. – 2020. – No. 5. - S. 24–29.
Yu, G., Liu, X., & Zhang, Y. (2023). Identification of immune-related hub genes in heart failure through bioinformatics approaches. Frontiers in Immunology, 14, 1098621. DOI: https://doi.org/10.33 89/fimmu.2023.1098621
Zhao, Q., Chen, Y., & Liu, J. (2023). The role of β-adrenergic receptor polymorphisms and MMP-9 gene variants in cardiovascular diseases: A systematic review. Genes, 14(3), 635. DOI: https://doi.org/ 10.3390/genes14030635